Diazotization and thiocyanate differentiate agonists from antagonists for the high- and low-affinity receptors of gamma-aminobutyric acid.
The differentiation of high- and low-affinity postsynaptic gamma-aminobutyric acid (GABA) receptors was examined in a washed cortical membrane preparation of the rat. The selective elimination of the high- and low-affinity GABA sites by the chaotropic anion thiocyanate and diazotization by p-diazobenzenesulfonic acid (DSA), respectively, offered two model systems for the separate sites. The [3H]GABA displacing potencies of some GABA agonists [GABA, 4,5,6,7-tetrahydro- isoxazole [4,5c]pyridine-3-ol (THIP), and muscimol] and antagonists [bicuculline methiodide (BCM), 3-alpha-hydroxy-16-imino-5 beta-17-aza-androstan-11-one (R-5135), and d-tubocurarine] and their slope factors were examined in these model systems and in control membranes. The displacing potency of the agonists was increased in the DSA-pretreated membranes and decreased in the presence of thiocyanate. The displacing potency of the antagonists was shifted in an opposite manner. The chaotropic effect of thiocyanate was reversible and not additive with the inhibitory effect of diazotization on the specific binding of GABA. Inhibition of specific GABA binding by pyridoxal-5-phosphate (PLP) could not be protected by GABA antagonists (BCM and R-5135) but only by agonists. The results can be interpreted in the framework of a dual (agonist-antagonist) receptor model, postulating a hydrophobic accessory site at the low-affinity GABA receptor. The effect of thiocyanate on the GABA receptor may result in the exposure of the hydrophobic accessory sites.
D000731:Androstanes / Q000378:metabolism; D000818:Animals; D001378:Azasteroids / Q000378:metabolism; D001557:Benzenesulfonates / Q000494:pharmacology*; D001640:Bicuculline / Q000031:analogs & derivatives / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003979:Diazonium Compounds / Q000494:pharmacology*; D007555:Isoxazoles / Q000378:metabolism; D008297:Male; D009118:Muscimol / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011963:Receptors, GABA-A; D013425:Sulfanilic Acids / Q000494:pharmacology*; D013861:Thiocyanates / Q000494:pharmacology*; D014403:Tubocurarine / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000731:Androstanes; D001378:Azasteroids; D001557:Benzenesulfonates; D003979:Diazonium Compounds; D007555:Isoxazoles; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D013425:Sulfanilic Acids; D013861:Thiocyanates; D009118:Muscimol; C017069:bicuculline methiodide; D005680:gamma-Aminobutyric Acid; C015542:gaboxadol; C031760:thiocyanate; C032061:RU 5135; D014403:Tubocurarine; D001640:Bicuculline; C000469:diazobenzenesulfonic acid